Pharmacology of ayahuasca administered in two repeated doses

Psychopharmacology

Volumn 219, Issue 4, 2012, Pages 1039-1053

  Dos Santos, Rafael G ^a,b,c   Grasa, Eva ^d   Valle, Marta ^a,c,d   Ballester, Maria Rosa ^b,c,d   Bouso, José Carlos ^a,b   Nomdedéu, Josep F ^b   Homs, Rosa ^b   Barbanoj, Manel J ^b,c,d   Riba, Jordi ^a,b,c,d  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Ayahuasca; Psychedelics; Repeated dose administration; Tolerance

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GROWTH HORMONE; HYDROCORTISONE; LACTOSE; N,N DIMETHYLTRYPTAMINE; PROLACTIN; PSYCHEDELIC AGENT;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; B LYMPHOCYTE; BLOOD LEVEL; BODY TEMPERATURE; CARDIOVASCULAR PARAMETERS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DIASTOLIC BLOOD PRESSURE; ELECTROENCEPHALOGRAPHY; FREEZE DRYING; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; NEUROENDOCRINOLOGY; NEUROPHYSIOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TEA; VOLUNTEER;

ADULT; BANISTERIOPSIS; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG TOLERANCE; GROWTH HORMONE; HALLUCINOGENS; HEART RATE; HUMANS; MALE; N,N-DIMETHYLTRYPTAMINE; PLANT EXTRACTS; TEA; TIME FACTORS; YOUNG ADULT;

EID: 84856670479     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2434-x     Document Type: Article

References (42)

1. 2A receptors in rabbit J Pharmacol Exp Ther 299 1066 1072 11714896 1:CAS:528:DC%2BD3MXovVCktLg%3D (Pubitemid 33107373)
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed., text rev.). APA, Washington DC
3. IM Anderson JF Deakin HE Miller 1996 The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers Psychopharmacology (Berl) 128 74 82 10.1007/s002130050112 1:CAS:528: DyaK28XnsVenu74%3D (Pubitemid 26379269)
4. 1A agonist, F13714: a microdialysis study in the rat Br J Pharmacol 149 170 178 16921393 10.1038/sj.bjp.0706859 (Pubitemid 44360098)
5. M Bellido E Rubiol J Ubeda C Estivill O López R Manteiga JF Nomdedéu 1998 Rapid and simple immunophenotypic characterization of lymphocytes using a new test Haematologica 83 681 685 9793249 1:STN:280:DyaK1M%2FgvFKntg%3D%3D (Pubitemid 28492147)
6. NS Buckholtz WO Boggan 1977 Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships Life Sci 20 2093 2099 18641 10.1016/0024-3205(77)90190-4 1:CAS:528:DyaE2sXlt1OjsLo%3D
7. JC Callaway DJ McKenna CS Grob GS Brito LP Raymon RE Poland EN Andrade EO Andrade DC Mash 1999 Pharmacokinetics of Hoasca alkaloids in healthy humans J Ethnopharmacol 65 243 256 10404423 10.1016/S0378-8741(98)00168-8 1:CAS:528:DyaK1MXksVWhsbo%3D (Pubitemid 29336019)
8. JM Cole WA Pieper 1973 The effects of N, N-dimethyltryptamine on operant behavior in squirrel monkeys Psychopharmacologia 29 107 112 4196867 10.1007/BF00422642 1:CAS:528:DyaE3sXkt1Ohtr0%3D
9. 2A receptor in C57BL/6 N mice Psychopharmacology (Berl) 215 581 593 10.1007/s00213-011-2207-6 1:CAS:528:DC%2BC3MXit1KlsLo%3D
10. First MB, Spitzer RL, Gibbon M, Williams JB (1999) Entrevista Clínica Estructurada para los Trastornos del Eje I del DSM-IV: Versión Clínica (SCID-VC). Masson, Barcelona
11. N Ghaziuddin K Welch J Greden 2003 Central serotonergic effects of i-chlorophenylpiperazine (mCPP) among normal control adolescents Neuropsychopharmacology 28 133 139 12496949 10.1038/sj.npp.1300006 1:CAS:528:DC%2BD3sXhtlWitrc%3D
12. JC Gillin E Cannon R Magyar M Schwartz RJ Wyatt 1973 Failure of N, N-dimethyltryptamine to evoke tolerance in cats Biol Psychiatry 7 213 220 4519415 1:CAS:528:DyaE2cXptFehsQ%3D%3D
13. JC Gillin J Kaplan R Stillman RJ Wyatt 1976 The psychedelic model of schizophrenia: the case of N, N-dimethyltryptamine Am J Psychiatry 133 203 208 1062171 1:CAS:528:DyaE28XhtFKnsbs%3D
14. PJ Gresch RL Smith RJ Barrett E Sanders-Bush 2005 Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex Neuropsychopharmacology 30 1693 1702 15756304 10.1038/sj.npp.1300711 1:CAS:528:DC%2BD2MXotFegur8%3D (Pubitemid 43086026)
15. H Isbell RE Belleville WA Fraser CR Logan 1956 Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication Arch Neurol Psychiatry 76 468 478
16. V Koudas A Nikolaou E Hourdaki SG Giakoumaki P Roussos P Bitsios 2009 Comparison of ketanserin, buspirone and propranolol on arousal, pupil size and autonomic function in healthy volunteers Psychopharmacology (Berl) 205 1 9 10.1007/s00213-009-1508-5 1:CAS:528:DC%2BD1MXjtFOnt7s%3D
17. B Kovacic EF Domino 1976 Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat J Pharmacol Exp Ther 197 495 502 1064726 1:CAS:528:DyaE28Xkt1yltbs%3D
18. X Lamas M Farré M Llorente J Camí 1994 Spanish version of the 49-item short form of the Addiction Research Center Inventory Drug Alcohol Depend 35 203 209 7956749 10.1016/0376-8716(94)90075-2 1:STN:280: DyaK2M%2FksVynug%3D%3D (Pubitemid 24186314)
19. 1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge Neuropsychopharmacology 20 628 639 10327431 10.1016/S0893-133X(98)00106-7 1:CAS:528:DyaK1MXjsValsr4%3D (Pubitemid 29189266)
20. WR Martin JW Sloan JD Sapira DR Jasinski 1971 Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 245 258 5554941 1:CAS:528:DyaE3MXhtl2gtLw%3D
21. DJ McKenna GHN Towers F Abbott 1984 Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and β-carboline constituents of ayahuasca J Ethnopharmacol 10 195 223 6587171 10.1016/0378-8741(84)90003-5 1:CAS:528:DyaL2cXks1Sjsb8%3D (Pubitemid 14081500)
22. 1A receptor agonist flesinoxan in normal volunteers Psychopharmacology (Berl) 164 27 32 10.1007/s00213-002-1177-0 1:CAS:528:DC%2BD38Xns1Ogsbo%3D (Pubitemid 35203839)
23. M Riad KC Watkins E Doucet M Hamon L Descarries 2001 Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors) J Neurosci 21 8378 8386 11606626 1:CAS:528:DC%2BD3MXnvVeqs7k%3D (Pubitemid 33051436)
24. Riba J (2003) Human pharmacology of ayahuasca. Doctoral dissertation, Universitat Autònoma de Barcelona. Available at http://www.tdx.cesca.es/ TDX-0701104-165104
25. J Riba A Rodriguez-Fornells G Urbano A Morte R Antonijoan M Monteiro JC Callaway MJ Barbanoj 2001 Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers Psychopharmacology (Berl) 154 85 95 10.1007/s002130000606 1:CAS:528: DC%2BD3MXjsVertrc%3D (Pubitemid 32186519)
26. J Riba A Rodriguez-Fornells RJ Strassman MJ Barbanoj 2001 Psychometric assessment of the Hallucinogen Rating Scale Drug Alcohol Depend 62 215 223 11295326 10.1016/S0376-8716(00)00175-7 1:STN:280:DC%2BD3M3ntVyltg%3D%3D (Pubitemid 32276069)
27. J Riba P Anderer A Morte G Urbano F Jane B Saletu MJ Barbanoj 2002 Topographic pharmaco-EEG mapping of the effects of the South American beverage ayahuasca in healthy volunteers Br J Clin Pharmacol 53 613 628 12047486 10.1046/j.1365-2125.2002.01609.x (Pubitemid 34621787)
28. J Riba M Valle G Urbano M Yritia A Morte MJ Barbanoj 2003 Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics J Pharmacol Exp Ther 306 73 83 12660312 10.1124/jpet.103.049882 1:CAS:528:DC%2BD3sXkvF2ltbg%3D (Pubitemid 36734359)
29. 2A receptor in the rabbit Psychopharmacology (Berl) 212 441 448 10.1007/s00213-010-2004-7 1:CAS:528:DC%2BC3cXhtFaltb7O
30. DE Rosenberg H Isbell EJ Miner 1963 Comparison of a placebo, N-dimethyltryptamine and 6-hydroxy-N-dimethyltryptamine in man Psychopharmacologia 4 39 42 14050410 10.1007/BF00429362 1:STN:280: DyaF2c%2FgvVSisw%3D%3D
31. DE Rosenberg H Isbell EJ Miner CR Logan 1964 The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide Psychopharmacologia 5 217 227 14138757 10.1007/BF00413244 1:CAS:528: DyaF2cXkt1OrtL4%3D
32. 2A) receptor desensitization can occur without down-regulation J Pharmacol Exp Ther 275 1638 1646 8531139 1:CAS:528:DyaK28XhvV2hsA%3D%3D
33. Santos RG, Valle M, Bouso JC, Nomdedéu JF, Rodríguez- Espinosa J, McIlhenny EH, Barker SA, Barbanoj MJ, Riba J (in press) Autonomic, neuroendocrine and immunological effects of ayahuasca. A comparative study with d-amphetamine
34. 1A receptor sensitivity Psychopharmacology (Berl) 132 296 302 10.1007/s002130050348 1:CAS:528: DyaK2sXlsVGqsr4%3D (Pubitemid 27351431)
35. 1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses Neuropsychopharmacology 13 93 104 8597527 10.1016/0893-133X(95)00025-9 1:CAS:528:DyaK2MXpvFyluro%3D
36. RL Smith H Canton RJ Barret E Sanders-Bush 1998 Agonist properties of N, N-dimethyltryptamine at 5-HT2A and 5-HT2C serotonin receptors Pharmacol Biochem Behav 61 323 330 9768567 10.1016/S0091-3057(98)00110-5 1:CAS:528: DyaK1cXmsVGks7g%3D (Pubitemid 28498215)
37. 2C, receptor Psychopharmacology (Berl) 144 248 254 10.1007/s002130051000 1:CAS:528:DyaK1MXkslKks7s%3D (Pubitemid 29307276)
38. RJ Strassman CR Qualls 1994 Dose-response study of N, N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects Arch Gen Psychiatry 51 85 97 8297216 10.1001/archpsyc.1994. 03950020009001 1:CAS:528:DyaK2cXis1Sgs7Y%3D (Pubitemid 24054310)
39. RJ Strassman CR Qualls EH Uhlenhuth R Kellner 1994 Dose-response study of N, N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch Gen Psychiatry 51 98 108 8297217 10.1001/archpsyc.1994.03950020022002 1:CAS:528:DyaK2cXis1Sgs7c%3D (Pubitemid 24054311)
40. RJ Strassman CR Qualls LM Berg 1996 Differential tolerance to biological and subjective effects of four closely spaced doses of N, N-dimethyltryptamine in humans Biol Psychiatry 39 784 795 8731519 10.1016/0006-3223(95)00200-6 1:CAS:528:DyaK28XjtVGks7s%3D (Pubitemid 26156742)
41. KW Tupper 2008 The globalization of ayahuasca: harm reduction or benefit maximization? Int J Drug Policy 19 297 303 18638702 10.1016/j.drugpo.2006.11.001 (Pubitemid 351970227)
42. M Yritia J Riba J Ortuno A Ramirez A Castillo Y Alfaro R De la Torre MJ Barbanoj 2002 Determination of N, N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of ayahuasca J Chromatogr B 779 271 281 10.1016/S1570-0232(02)00397-5 1:CAS:528: DC%2BD38XovF2ntbY%3D (Pubitemid 35279454)